ORIGINAL RESEARCH
Accepted on 05 Mar 2025
Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: Trelegy Ellipta for Real Asthma Control Study (T-RECS)
doi 10.3389/falgy.2025.1537501